AG˹ٷ

STOCK TITAN

SASOL LIMITED: TRADING STATEMENT FOR THE YEAR ENDED 30 JUNE 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Sasol Limited (NYSE:SSL) has released its trading statement for the year ended June 30, 2025, announcing significant earnings improvements. The company expects Earnings Per Share (EPS) to increase by over 100% to between R7.00 and R12.00, compared to the prior year's loss of R69.94. Headline Earnings Per Share (HEPS) is projected to rise 85-100% to R33.60-R36.30.

However, Adjusted EBITDA is expected to decrease by 10-17% to R50-54 billion. The improved earnings were driven by higher chemical prices, lower impairments of R20.7 billion (vs R74.9 billion prior year), and a R4.3 billion settlement from Transnet. These gains were partially offset by a 15% decline in average Rand per barrel oil prices and a 3% decrease in sales volumes.

Sasol Limited (NYSE:SSL) ha pubblicato il trading statement relativo all'esercizio chiuso il 30 giugno 2025, evidenziando un netto miglioramento degli utili. La società prevede che l'Earnings Per Share (EPS) aumenterà di oltre il 100%, portandosi tra R7.00 e R12.00 rispetto alla perdita di R69.94 dell'anno precedente. Il Headline Earnings Per Share (HEPS) dovrebbe crescere dell'85-100% fino a R33.60-R36.30.

Di contro, il Adjusted EBITDA è previsto in calo del 10-17%, a R50-54 miliardi. Il progresso degli utili è stato favorito da prezzi chimici più elevati, svalutazioni più contenute pari a R20.7 miliardi (rispetto a R74.9 miliardi l'anno scorso) e da un accordo di R4.3 miliardi con Transnet; questi effetti positivi sono stati parzialmente compensati da un calo del 15% del prezzo medio del petrolio in rand al barile e da una riduzione del 3% dei volumi venduti.

Sasol Limited (NYSE:SSL) publicó su trading statement para el ejercicio cerrado el 30 de junio de 2025, mostrando una mejora notable en sus resultados. La compañía espera que las ganancias por acción (EPS) aumenten más del 100%, situándose entre R7.00 y R12.00 frente a la pérdida de R69.94 del año anterior. Se proyecta que el Headline Earnings Per Share (HEPS) suba entre un 85% y un 100%, hasta R33.60-R36.30.

No obstante, se espera que el EBITDA ajustado disminuya entre un 10% y un 17%, hasta R50-54 mil millones. La mejora del beneficio se debe a precios químicos más altos, menores deterioros por R20.7 mil millones (vs R74.9 mil millones el año previo) y a un acuerdo de R4.3 mil millones con Transnet; estos efectos positivos se vieron en parte compensados por una caída del 15% en el precio medio del petróleo en rand por barril y una reducción del 3% en los volúmenes vendidos.

Sasol Limited (NYSE:SSL)� 2025� 6� 30일로 마감� 회계연도� 대� 거래 공시� 발표하며 실적� 크게 개선되었음을 알렸�. 회사� 주당순이�(EPS)� 100% 이상 증가하여 R7.00에서 R12.00 사이가 � 것으� 예상하며, 이는 전년� R69.94 손실� 비교되는 수치�. 헤드라인 주당순이�(HEPS)은 85~100% 상승� R33.60~R36.30� � 것으� 전망된다.

다만 조정 EBITDA� 10~17% 감소� R50~54십억� � 것으� 보인�. 실적 개선은 화학제품 가� 상승, R20.7십억� 낮은 손상(전년 R74.9십억 대�), Transnet로부터의 R4.3십억 합의금에 기인하며, 이러� 요인들은 평균 랜드� 배럴 유가 15% 하락� 판매� 3% 감소� 의해 일부 상쇄됐다.

Sasol Limited (NYSE:SSL) a publié son trading statement pour l'exercice clos le 30 juin 2025, annonçant une nette amélioration des résultats. La société prévoit que le bénéfice par action (EPS) augmentera de plus de 100%, se situant entre R7.00 et R12.00, contre une perte de R69.94 l'année précédente. Le Headline Earnings Per Share (HEPS) devrait progresser de 85 à 100% pour atteindre R33.60-R36.30.

Cependant, l'EBITDA ajusté devrait diminuer de 10 à 17%, à R50-54 milliards. L'amélioration des bénéfices est due à des prix chimiques plus élevés, à des dépréciations moindres de R20.7 milliards (contre R74.9 milliards l'an passé) et à un règlement de R4.3 milliards avec Transnet ; ces gains sont partiellement compensés par une baisse de 15% du prix moyen du pétrole en rand par baril et par une diminution de 3% des volumes vendus.

Sasol Limited (NYSE:SSL) hat seinen Trading Statement für das am 30. Juni 2025 endende Geschäftsjahr veröffentlicht und meldet deutliche Ergebnisverbesserungen. Das Unternehmen erwartet, dass das Ergebnis je Aktie (EPS) um über 100% steigt und sich zwischen R7.00 und R12.00 einpendelt, nach einem Verlust von R69.94 im Vorjahr. Das Headline Earnings Per Share (HEPS) soll um 85�100% auf R33.60–R36.30 zulegen.

Gleichzeitig wird jedoch ein Rückgang des bereinigten EBITDA um 10�17% auf R50�54 Milliarden erwartet. Die besseren Ergebnisse sind auf höhere Chemikalienpreise, geringere Wertminderungen von R20.7 Milliarden (vs. R74.9 Milliarden im Vorjahr) und eine R4.3 Milliarden Einigung mit Transnet zurückzuführen; dem standen ein 15%iger Rückgang des durchschnittlichen Ölpreises in Rand pro Barrel und ein 3%iger Rückgang des Absatzvolumens gegenüber.

Positive
  • None.
Negative
  • Adjusted EBITDA expected to decrease by 10-17% to R50-54B
  • 15% decline in average Rand per barrel Brent crude oil price
  • 3% decrease in sales volumes due to lower production/market demand
  • R13.1B impairment of costs capitalized for Secunda and Sasolburg refineries
  • R4.4B impairment of Mozambique assets due to higher country risk premium
  • R3.2B impairment of Italy Care Chemicals CGU due to lower sales margins

Insights

Sasol reports dramatic EPS recovery from prior year losses, but underlying EBITDA declined 10-17% amid challenging market conditions.

Sasol's trading statement reveals a remarkable turnaround in its headline performance metrics while showing concerning trends in operational profitability. The company expects EPS to swing from a R69.94 loss to between R7.00 and R12.00 per share - an improvement exceeding 100%. Similarly, HEPS is projected to increase by 85%-100% to between R33.60 and R36.30 from R18.19.

However, beneath these headline improvements lies a more concerning operational reality. Adjusted EBITDA - a crucial measure of operational profitability - is expected to decrease by 10%-17% to between R50 billion and R54 billion from R60 billion. This divergence between EPS growth and EBITDA decline indicates the earnings improvement stems primarily from non-operational factors rather than business fundamentals.

The key positive drivers include higher chemical prices, cost control measures, significantly lower impairments (R20.7 billion versus R74.9 billion previously), a R4.3 billion Transnet settlement, and reduced rehabilitation provisions. These gains were partially offset by a 15% decline in Rand per barrel Brent crude prices, deteriorating refining margins, a 3% decrease in sales volumes, and smaller unrealized gains on monetary assets.

The impairment situation remains challenging with Secunda and Sasolburg liquid fuels refinery CGUs still fully impaired despite management actions, and additional impairments in Mozambique exploration assets (R4.4 billion) and Italy Care Chemicals (R3.2 billion). The only bright spot was a R1 billion impairment reversal for China Care Chemicals following sustained business improvement.

The overall picture suggests Sasol faces significant operational headwinds despite the improved headline numbers, with commodity price pressures and volume challenges weighing on core performance metrics.

JOHANNESBURG, Aug. 12, 2025 /PRNewswire/ -- We refer to the SENS announcement of 22 July 2025, on the release of the quarterly production and sales metrics, where Sasol indicated that earnings per share (EPS) are expected to increase by more than 20%.

In terms of paragraph 3.4(b)(i) of the Listing Requirement of the JSE Limited, stakeholders are advised that, for the year ended 30 June 2025:

  • Earnings per share (EPS) is expected to increase by more than 100% compared to the prior year, to between R7,00 and R12,00 (prior year loss per share of R69,94); and
  • Headline earnings per share (HEPS) is expected to increase by between 85% and 100% compared to the prior year, to be between R33,60 and R36,30 (prior year HEPS of R18,19); and

Adjusted earnings before interest, tax, depreciation and amortisation (adjusted EBITDA*) is expected to decrease by between 10% and 17% compared to the prior year, to between R50billion and R54billion (prior year adjusted EBITDA of R60billion)

The increase in earnings for the year was supported by management actions and driven by:

  • ­n increase in the average chemicals basket prices and strict cost control;
  • Significantly lower impairments of R20,7 billion (before tax) (summary below), compared to R74,9 billion in the prior year;
  • Thederecognition of deferred tax asset in the prior year of R15,3 billion, mainly relating to an assessed loss carry forward on our Chemicals America operations which is not anticipated to be utilised;
  • Transnet SOC Limited net cash settlement of R4,3 billion (before tax); and
  • Reduction in asset rehabilitation provision of R2,9 billion in the current year compared to a reduction of R0,8 billion in the prior year;

The increase in earnings was partially offset by:

  • ­ 15% decline in the average Rand per barrel of Brent crude oil price as well as a significant decline in refining margins and fuel price differentials;
  • A 3% decrease in sales volumes associated with lower production and/or lower market demand as detailed in the Production and Sales Metrics published on 22 July 2025, which can be found on our website:; and
  • Lowerunrealised gains of R2 billion on the translation of monetary assets and liabilities, and valuation of financial instruments and derivative contracts compared to unrealised gains of R4,7 billion in the prior year.

The following is a summary of significant impairments and reversal of impairment in the current year:

  • TheSecunda and Sasolburg liquid fuels refinery cash generating units (CGU) remain fully impaired. The recoverable amount improved through management actions but was negatively impacted by lower forecast macro-economic assumptions. Additional management initiatives need to be further progressed before the benefits can be incorporated in the impairment calculations. Costs capitalised during the current year of R13,1 billion have been impaired;
  • Impairment of the Production Sharing Agreement (PSA) and PT5-C exploration assets in Mozambique of R4,4billion, driven by an increase in the weighted average cost of capital (WACC) attributable to independently calculated higher country risk premium. The PSA was also impacted by a marginal reduction in estimated gas volumes, as well as lower sales prices of oil related products;
  • Impairment of Italy Care ChemicalsCGU of R3,2billion, driven by lower for longer forecast sales margins. The CGU is fully impaired; and
  • Reversal of impairment of the China Care ChemicalsCGU of R1billion following a sustained improvement in the business results.

The financial information underpinning this trading statement has not been reviewed and reported on by the Company's external auditors.

Sasol will present its 2025 financial results on Monday, 25 August 2025 at 09h00 (SA time). This will be followed by a market call, hosted by President and Chief Executive Officer, Simon Baloyi, and Chief Financial Officer, Walt Bruns, to address questions.

Please connect to the call via the webcast link: or via teleconference call link:

* Adjusted EBITDA is calculated by adjusting operating profit for depreciation, amortisation, share-based payments, remeasurement items, change in discount rates of our rehabilitation provisions, all unrealised translation gains and losses, and all unrealised gains and losses on our derivatives and hedging activities.

Adjusted EBITDA is not a defined term under International Financial Reporting Standards and may not be comparable with similarly titled measures reported by other companies. The aforementioned adjustments are the responsibility of the directors of Sasol. The adjustments have been prepared for illustrative purposes only and due to their nature, may not fairly presentSasol´s financial position, changes in equity, results of operations or cash flows.

For further information, please contact:
Sasol Investor Relations,
Tiffany Sydow, VP Investor Relations
Telephone: +27 (0) 71 673 1929
[email protected]

Disclaimer - Forward-looking statements

Sasol may, in this document, make certain statements that are not historical facts and relate to analyses and other information which are based on forecasts of future results and estimates of amounts not yet determinable. These statements may also relate to our future prospects, expectations, developments, and business strategies. Examples of such forward-looking statements include, but are not limited to, the capital cost of our projects and the timing of project milestones; our ability to obtain financing to meet the funding requirements of our capital investment programme, as well as to fund our ongoing business activities and to pay dividends; statements regarding our future results of operations and financial condition, and regarding future economic performance including cost containment, cash conservation programmes and business optimisation initiatives; recent and proposed accounting pronouncements and their impact on our future results of operations and financial condition; our business strategy, performance outlook, plans, objectives or goals; statements regarding future competition, volume growth and changes in market share in the industries and markets for our products; our existing or anticipated investments, acquisitions of new businesses or the disposal of existing businesses, including estimates or projection of internal rates of return and future profitability; our estimated oil, gas and coal reserves; the probable future outcome of litigation, legislative, regulatory and fiscal developments, including statements regarding our ability to comply with future laws and regulations; future fluctuations in refining margins and crude oil, natural gas and petroleum and chemical product prices; the demand, pricing and cyclicality of oil, gas and petrochemical product prices; changes in the fuel and gas pricing mechanisms in South Africa and their effects on prices, our operating results and profitability; statements regarding future fluctuations in exchange and interest rates and changes in credit ratings; total shareholder return; our current or future products and anticipated customer demand for these products; assumptions relating to macroeconomics; climate change impacts and our climate change strategies, our development of sustainability within our businesses, our energy efficiency improvement, carbon and greenhouse gas emission reduction targets, our net zero carbon emissions ambition and future low-carbon initiatives, including relating to green hydrogen and sustainable aviation fuel; our estimated carbon tax liability; cyber security; and statements of assumptions underlying such statements. Words such as "believe", "anticipate", "expect", "intend", "seek", "will", "plan", "could", "may", "endeavour", "target", "forecast" and "project" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and there are risks that the predictions, forecasts, projections, and other forward-looking statements will not be achieved. If one or more of these risks materialise, or should underlying assumptions prove incorrect, our actual results may differ materially from those anticipated. You should understand that a number of important factors could cause actual results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward-looking statements. These factors and others are discussed more fully in our most recent annual report on Form 20-F filed on 6 September 2024 and in other filings with the United States Securities and Exchange Commission. The list of factors discussed therein is not exhaustive; when relying on forward-looking statements to make investment decisions, you should carefully consider foregoing factors and other uncertainties and events, and you should not place undue reliance on forward-looking statements. Forward-looking statements apply only as of the date on which they are made, and we do not undertake any obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

Cision View original content:

SOURCE Sasol Limited

FAQ

What is Sasol's (SSL) expected EPS for the year ended June 30, 2025?

Sasol expects EPS to increase by over 100% to between R7.00 and R12.00, compared to the prior year's loss per share of R69.94.

How much will Sasol's (SSL) Adjusted EBITDA decrease in 2025?

Sasol's Adjusted EBITDA is expected to decrease by 10-17% to between R50 billion and R54 billion, compared to R60 billion in the prior year.

What are the main factors driving Sasol's earnings improvement in 2025?

Key factors include higher chemical basket prices, lower impairments (R20.7B vs R74.9B), R4.3B Transnet settlement, and R2.9B reduction in asset rehabilitation provision.

What major impairments did Sasol (SSL) report in 2025?

Major impairments include R13.1B for Secunda and Sasolburg refineries, R4.4B for Mozambique assets, and R3.2B for Italy Care Chemicals.

When will Sasol (SSL) present its 2025 financial results?

Sasol will present its 2025 financial results on Monday, August 25, 2025, at 09:00 SA time.
Sasol

NYSE:SSL

SSL Rankings

SSL Latest News

SSL Latest SEC Filings

SSL Stock Data

3.17B
636.32M
2.54%
0.97%
Specialty Chemicals
Basic Materials
South Africa
Johannesburg